Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 90 for transplant

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

    Rochester, MN

  2. Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

    Scottsdale/Phoenix, AZ

  3. Autologous Induced Pluripotent Stem Cells of Cardiac Lineage Delivered Into Heart Muscle for Congenital Heart Disease

    Rochester, MN

  4. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

    Rochester, MN

  5. Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (COLT)

    Rochester, MN

  6. Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf® Monitoring

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. A Study of TCD601 in de Novo Renal Transplant Recipients

    Rochester, MN

  8. Cryoprobe Biopsy in Chronic Rejection in Lung Transplant Recipients

    Rochester, MN

  9. Promoting Physical Activity in Liver Transplant Candidates With Advanced Liver Disease by Employing Competition

    Scottsdale/Phoenix, AZ

  10. A Trial of Felzartamab in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR)

    Rochester, MN

.

Mayo Clinic Footer